DW-1350 |
Catalog No.GC31921 |
DW-1350 es un antagonista del receptor LTB4.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 491577-61-8
Sample solution is provided at 25 µL, 10mM.
DW-1350 is a LTB4 receptor antagonist.
DW-1350 is a LTB4 receptor antagonist. DW-1350 shows inhibitory effects against osteoclast in terms of differentiation, formation, fusion and bone absorption[1].
[1]. Kang JH, et al. 5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1expression. Bioorg Med Chem. 2015 Nov 1;23(21):7069-78.
Average Rating: 5
(Based on Reviews and 26 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *